PHK
STRO icon

Point72 Hong Kong’s Sutro Biopharma STRO Stock Holding History

Point72 Hong Kong’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-883
Closed -$46K – 2397
2022
Q2 		$46K Buy
+883
New +$49.3K ﹤0.01% 1387
2021
Q4 		– Sell
-133
Closed -$25K – 2364
2021
Q3 		$25K Buy
133
+66
+99% +$12.5K ﹤0.01% 1660
2021
Q2 		$12K Sell
67
-16
-19% -$3.13K ﹤0.01% 1719
2021
Q1 		$19K Buy
+83
New +$19.7K ﹤0.01% 1488
2020
Q3 		– Sell
-74
Closed -$6K – 1515
2020
Q2 		$6K Buy
+74
New +$7.1K ﹤0.01% 1029

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Point72 Hong Kong's STRO Position: Q3 2022 in Review

Point72 Hong Kong sold out of Sutro Biopharma (STRO) in Q3 2022, closing a stake of 883 shares — an estimated $46K sold.

Point72 Hong Kong first reported a position in STRO in Q2 2020 and held it in 5 quarters. The position peaked at $46K in Q2 2022. 113 funds tracked by Wall St. Rank hold STRO as of Q3 2022.

  • Point72 Hong Kong reported no remaining Sutro Biopharma position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 883 Sutro Biopharma shares in Q3 2022, an estimated $46K.
  • Point72 Hong Kong first reported a position in Sutro Biopharma in Q2 2020 and held it in 5 quarters.
  • Point72 Hong Kong's Sutro Biopharma position peaked at $46K in Q2 2022.
  • 113 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.